Persistence of cefotetan on red blood cells

Transfusion

Volumn 44, Issue 6, 2004, Pages 849-852

  Davenport, Robertson D ^a   Judd, W John ^a   Dake, Louann R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DITHIOTHREITOL; DRUG ANTIBODY; FICIN;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD LEVEL; BLOOD SAMPLING; DOSE RESPONSE; DRUG BINDING; DRUG ERYTHROCYTE LEVEL; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODY SPECIFICITY; BLOOD TRANSFUSION; CEFOTETAN; CEPHALOSPORINS; CROSS REACTIONS; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ERYTHROCYTE MEMBRANE; FICAIN; FOLLOW-UP STUDIES; HUMANS; TIME FACTORS;

EID: 2942590645     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03360.x     Document Type: Article

References (6)

1. Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239-46.
2. Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia: a review of 85 cases. Adv Drug React Roxicol Rev 2002;21:101-7.
3. Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynec 1999;181:103-4.
4. Ray EK, Warkentin TE, O'Hoski PL, Gregor P. Delayed onset of life-threatening immune hemolysis after perioperative antimicrobial prophylaxis with cefotetan. Can J Surg 2000;43:461-2.
5. Martin C, Thomachot L, Albanses J. Clinical pharmacokinetics of cefotetan. Clin Pharmacokinet 1994;26:248-58.
6. Judd WJ. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific, 1994.